Showing results (1281-1290 of 2,458) with videos related to
Sort By:
Pageof 246
Therapie|May 8, 2021
[Hypophosphatemia following the administration of intravenous iron formulations: A case report and literature review]Anne-Lise Lecoq, Catherine Dong, Franck Carbonnel, et al.Therapie|June 5, 2020
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice]Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.Therapie|May 19, 2020
"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance CentersAlexandre Gérard, Serena Romani, Audrey Fresse, et al.Therapie|June 1, 2020
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidenceM Roustit, R Guilhaumou, M Molimard, et al.Therapie|May 20, 2020
Diabetes and COVID-19Béatrice Bouhanick, Jean-Luc Cracowski, Jean-Luc Faillie, et al.Therapie|August 29, 2021
Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patientsEmin Pala, Suleyman Ersoy, Velittin Selcuk Engin, et al.Therapie|September 1, 1980
[New trends on biochemical mechanism of action of benzodiazepines (author's transl)]M Valli, D PringueyTherapie|July 1, 1989
[Effects of 3 doses of maprotiline (25, 50 and 75 mg) on alertness and memory in healthy volunteers]D Warot, P Danjou, L Lacomblez, et al.Therapie|May 2, 2020
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort studyCanelle Mazaud, Laurence FardetTherapie|May 2, 2020
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in FranceJulien Jacquot, Vanessa Rousseau, Claire de Canecaude, et al.Pageof 246